Lilly supports Haryana State-FDA action against counterfeit medicines
Company responds to regulatory action and outlines guidance on procurement and product identification
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
SPARC to sell Rare Paediatric Disease Priority Review Voucher for $195 million
Voucher granted for Sezaby approval to be divested under asset purchase agreement
Parexel acquires Vitrana to expand pharmacovigilance technology platform
Acquisition integrates AI-enabled PV solutions with clinical and safety services
CDSCO West Zone to conduct webinar on WHO-GMP and COPP application process via ONDLS
Refresher session scheduled on April 29 for industry members and regulators
Dr Reddy’s receives Health Canada approval for generic Semaglutide Injection
Market authorisation covers 2 mg and 4 mg pen presentations in Canada
VESCOP, ENTOD and APTI Maharashtra host Vision 360 symposium on ophthalmic innovation
Symposium focuses on translating research into clinical application in ophthalmology
AKUMS launches Aztreonam-Avibactam Injection for multidrug-resistant infections
Therapy targets gram-negative bacterial infections in critical care settings
Alvarez & Marsal India appoints Nitin Lath as MD in Corporate Finance
Appointment to focus on private equity and M&A advisory in life sciences sector
Zydus receives approval to conduct Phase III trials of Zintrodiazine for malaria in India
Two studies to evaluate efficacy and safety in Plasmodium falciparum and Plasmodium vivax infections